ArticleJournal for immunotherapy of cancer2023

Suitability of tumor-associated antibodies as predictive biomarker for response to immune checkpoint inhibitors in patients with melanoma: a short report.

Karlijn de Joode et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.